Cargando…

Impact of age on cardiovascular drug use in patients with chronic kidney disease

BACKGROUND: Elderly patients with chronic kidney disease (CKD) are often excluded from clinical trials; this may affect their use of essential drugs for cardiovascular complications. We sought to assess the impact of age on cardiovascular drug use in elderly patients with CKD. METHODS: We used basel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villain, Cédric, Liabeuf, Sophie, Metzger, Marie, Combe, Christian, Fouque, Denis, Frimat, Luc, Jacquelinet, Christian, Laville, Maurice, Briançon, Serge, Pisoni, Ronald L, Mansencal, Nicolas, Stengel, Bénédicte, Massy, Ziad A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147308/ https://www.ncbi.nlm.nih.gov/pubmed/32296525 http://dx.doi.org/10.1093/ckj/sfz063

Ejemplares similares

Urea levels and cardiovascular disease in patients with chronic kidney disease
por: Laville, Solène M, et al.
Publicado: (2022)

Consequences of oral antithrombotic use in patients with chronic kidney disease
por: Laville, Solène M., et al.
Publicado: (2021)

The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study
por: Stengel, Bénédicte, et al.
Publicado: (2014)

Longitudinal uric acid has nonlinear association with kidney failure and mortality in chronic kidney disease
por: Prezelin-Reydit, Mathilde, et al.
Publicado: (2023)

Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease
por: El Chamieh, Carolla, et al.
Publicado: (2023)

Urinary Sodium-to-Potassium Ratio and Blood Pressure in CKD
por: Alencar de Pinho, Natalia, et al.
Publicado: (2020)

Probiotic Intake and Inflammation in Patients With Chronic Kidney Disease: An Analysis of the CKD-REIN Cohort
por: Wagner, Sandra, et al.
Publicado: (2022)

Vascular access conversion and patient outcome after hemodialysis initiation with a nonfunctional arteriovenous access: a prospective registry-based study
por: Alencar de Pinho, Natalia, et al.
Publicado: (2017)

Predictors of nonfunctional arteriovenous access at hemodialysis initiation and timing of access creation: A registry-based study
por: Alencar de Pinho, Natalia, et al.
Publicado: (2017)

Prediction of chronic kidney disease after acute kidney injury in ICU patients: study protocol for the PREDICT multicenter prospective observational study
por: Geri, Guillaume, et al.
Publicado: (2018)

The Public Health Burden of Cardiomyopathies: Insights from a Nationwide Inpatient Study
por: Lannou, Simon, et al.
Publicado: (2020)

Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD
por: Massy, Ziad A., et al.
Publicado: (2019)

Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?
por: El Chamieh, Carolla, et al.
Publicado: (2022)

Practice patterns of dialysis access and outcomes in patients wait-listed early for kidney transplantation
por: Sylvestre, Raphaëlle, et al.
Publicado: (2020)

From old uraemic toxins to new uraemic toxins: place of ‘omics’
por: Massy, Ziad A, et al.
Publicado: (2018)

The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease
por: Liabeuf, Sophie, et al.
Publicado: (2015)

Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins
por: Laville, Solène M., et al.
Publicado: (2021)

Prescription of Direct Oral Anticoagulants to Patients With Moderate-to-Advanced CKD: Too Little or Just Right?
por: Liabeuf, Sophie, et al.
Publicado: (2021)

Does kidney transplantation influence a form of discrimination for antihypertensive drugs prescriptions?
por: Cheddani, Lynda, et al.
Publicado: (2021)

Analysis, evaluation and adaptation of the ReTransQoL: a specific quality of life questionnaire for renal transplant recipients
por: Beauger, Davy, et al.
Publicado: (2013)

Should We Use Standard Survival Models or the Illness-Death Model for Interval-Censored Data to Investigate Risk Factors of Chronic Kidney Disease Progression?
por: Boucquemont, Julie, et al.
Publicado: (2014)

Predialysis therapeutic care and health-related quality of life at dialysis onset (The pharmacoepidemiologic AVENIR study)
por: Boini, Stephanie, et al.
Publicado: (2011)

Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
por: Liabeuf, Sophie, et al.
Publicado: (2018)

Protein-Bound Uremic Toxins: New Insight from Clinical Studies
por: Liabeuf, Sophie, et al.
Publicado: (2011)

Factors associated with health-related quality of life in renal transplant recipients: results of a national survey in France
por: Gentile, Stéphanie, et al.
Publicado: (2013)

Kidney Function Decline and Apparent Treatment-Resistant Hypertension in the Elderly
por: Kaboré, Jean, et al.
Publicado: (2016)

Difference in Profiles of the Gut-Derived Tryptophan Metabolite Indole Acetic Acid between Transplanted and Non-Transplanted Patients with Chronic Kidney Disease
por: Liabeuf, Sophie, et al.
Publicado: (2020)

Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based study
por: Ayav, Carole, et al.
Publicado: (2016)

Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries
por: Stengel, Bénédicte, et al.
Publicado: (2020)

Total calcium-sensing receptor expression in circulating monocytes is increased in rheumatoid arthritis patients with severe coronary artery calcification
por: Paccou, Julien, et al.
Publicado: (2014)

Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease
por: Kaboré, Jean, et al.
Publicado: (2016)

The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial
por: Bennis, Youssef, et al.
Publicado: (2019)

Targets for parathyroid hormone in secondary hyperparathyroidism: is a “one-size-fits-all” approach appropriate? A prospective incident cohort study
por: Laurain, Emmanuelle, et al.
Publicado: (2014)

The Authors Reply
por: Alencar de Pinho, Natalia, et al.
Publicado: (2020)

Day-Time Declamping Is Associated with Better Outcomes in Kidney Transplantation: The Circarein Study
por: Montaigne, David, et al.
Publicado: (2021)

Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients
por: Lenglet, Aurélie, et al.
Publicado: (2013)

Comparison of homocitrulline and carbamylated albumin as biomarkers of carbamylation reactions in hemodialyzed patients
por: Lenglet, Aurelie, et al.
Publicado: (2023)

Serum biomarkers of iron stores are associated with worse physical health-related quality of life in nondialysis-dependent chronic kidney disease patients with or without anemia
por: Guedes, Murilo, et al.
Publicado: (2021)

Association between Free Light Chain Levels, and Disease Progression and Mortality in Chronic Kidney Disease
por: Desjardins, Lucie, et al.
Publicado: (2013)

Prescription of renin‐angiotensin‐aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care
por: Pecoits‐Filho, Roberto, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6vte4atubggv7l7iph6dimfh0d